Entero Healthcare Solutions IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1600.00 Cr. The company is based in New Delhi and caters to Healthcare sector. Dam Capital Advisors (Formerly Idfc Securities ) , ICICI Securities , Jefferies India , Jm Financial are the merchant bankers of Entero Healthcare Solutions IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th November -0001.
Entero Healthcare Solutions IPO posted revenues of ₹ 3797.96 crores and PAT of ₹ 23.28 crores in FY23 on annualised basis.Financial results of Entero Healthcare Solutions IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Jun-22 | FY22 | FY21 | FY20 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 1505.95 | 1308.73 | 1125.98 | 833.79 | |
Net Worth | 660.55 | 597.66 | 563.22 | 487.06 | |
Total Debt | 488.68 | 367.51 | 373.52 | 141.70 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
1895.50
3,791.00 |
3300.21 | 2522.07 | 1779.74 | |
EBITDA
EBITDA on annualised basis |
54.37
108.74 |
64.01 | 24.44 | 21.55 | |
PAT
PAT on annualised basis |
11.37
22.74 |
-11.56 | -29.92 | -15.54 |
Entero Healthcare Solutions IPO PAT Margin is 0.60 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Entero Healthcare Solutions IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Jun-22 | FY22 | FY21 | FY20 |
---|---|---|---|---|
EBITDA Margin (%) | 2.87 | 1.94 | 0.97 | 1.21 |
PAT Margin (%) | 0.60 | -0.35 | -1.19 | -0.87 |
EPS (₹) | 2.95 | -3.10 | -9.22 | -5.29 |
ROE (%) | 1.72 | -1.93 | -5.31 | -3.19 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 0.76 | -0.88 | -2.66 | -1.86 |
Debt to Equity | 0.74 | 0.61 | 0.66 | 0.29 |
The market Capitalisation of Entero Healthcare Solutions IPO is ₹ 3021.21 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Entero Healthcare Solutions IPO prospectus highlights an Return on Equity (ROE) of 1.72 % , Return on Assets (ROA) of 0.76 %, and an EBITDA Margin of 2.87 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Entero Healthcare Solutions IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Entero Healthcare Solutions IPO is ₹ 3021.21 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Entero Healthcare Solutions IPO has a Price-to-Earnings (PE) ratio of 9.84 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Entero Healthcare Solutions IPO reported revenue of ₹ 3797.96 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Entero Healthcare Solutions IPO provide insights into sales growth, market demand, and business scalability.
Entero Healthcare Solutions recorded an EBITDA of ₹ 108.74 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Entero Healthcare Solutions Profit After Tax (PAT) is ₹ 22.74 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Entero Healthcare Solutions operates in Healthcare and Healthcare Product Distributor In India. The Issue is listed on BSE,NSE in Feb, 2024. Entero Healthcare Solutions IPO size was 1600.00 with Issue price of 1258.00 .
Merchant Banker(s) of Entero Healthcare Solutions IPO: Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , ICICI Securities Limited , Jefferies India Private Limited , Jm Financial Limited
Entero Healthcare Solutions IPO subscription was 1.53 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Entero Healthcare Solutions IPO listed at a listing price of 1149.50 against the offer price of 1258.00.
The current market price of Entero Healthcare Solutions is 1118.30.
Why Us?